Imperial College London Apr 16 2025 Patients who receive an add-on medication soon after a heart attack have a significantly better prognosis than those who receive it later, or not all. This is according to a new study from researchers at Lund University in Sweden and Imperial College London. The findings suggest that treating patients earlier with a combination of statins and the cholesterol-lowering drug ezetimibe could prevent thousands of new heart attacks over a decade.  Cardiovascular